What is happening in the case right now, and what does that mean for someone new?
A panel of federal judges has sent each maker’s cases to its own judge. The Boston Scientific group started on June 5, 2026, and the Abbott and Nevro groups started on October 2, 2026. Each group handles pretrial work together, but each person’s injury and cause are still looked at one by one.
Boston Scientific (MDL 3181)
Judge Josephine L. Staton of the federal court for central California leads this group. On October 1, 2026, the panel’s report listed 41 pending cases in it. The people who sued say Boston Scientific won approval using studies of other companies’ devices. They say it then changed its devices through a chain of approval updates to avoid closer review and new testing.
They also say company sales staff helped place leads and set up devices during surgery. They call that practicing medicine without a license. The order that created the group does not name any device models.
Separately, Boston Scientific told customers in June 2026 to stop using unused Infinion CX leads, models SC-2317-50 and SC-2317-70. The FDA notice says stress where the lead is anchored may cause breaks or weak stimulation. It says the recall does not affect leads already implanted, and it advises no extra checks beyond routine follow-up. The court order read here does not mention this recall.
Abbott (MDL 3194)
Judge Lindsay C. Jenkins of the federal court for northern Illinois leads this group. The order said 26 cases were pending in 13 federal court districts when it was signed. The people who sued say Abbott used approval updates to bring out changed devices without new testing, and did not warn about risks.
Those asking for the group named three common injuries: nerve injury from electric current, tissue damage from overheating and failed leads. Almost all say Abbott sales staff programmed or adjusted devices, often with no doctor present. The order does not name any device models.
Nevro (MDL 3195)
Judge Haywood S. Gilliam, Jr., of the federal court for northern California leads this group. The order said 23 cases were pending in 10 federal court districts. The companies named are Nevro, now called Nevro LLC, and Globus Medical.
The people who sued describe shocks, incontinence (loss of bladder or bowel control) and leg weakness from the electric signals. They also describe burns and leads that moved, and devices that did not relieve pain. Two cases involve the HFX iQ device and claim a design flaw. Almost all say sales staff changed settings or moved leads, and were trained to make misleading statements.
Other brands
In June 2026 the panel chose not to put every maker’s cases into one group. It said each maker has its own devices and its own approval history. Some related cases named Medtronic, but these orders did not create a Medtronic group. If you have another brand, a lawyer can tell you what options apply.